Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer

Lignende værker

• Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
  af: Kandula, Shravan, et al.
  Udgivet: (2015)
• The 21-Gene Recurrence Score and Locoregional Recurrence in Breast Cancer Patients
  af: Jegadeesh, Naresh K., et al.
  Udgivet: (2014)
• Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
  af: Gwark, Sungchan, et al.
  Udgivet: (2021)
• Vascular Effects of Estrogenic Menopausal Hormone Therapy
  af: Reslan, Ossama M., et al.
  Udgivet: (2012)
• CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy
  af: Schlafstein, Ashley J., et al.
  Udgivet: (2018)